Yahoo · Oct 14, 2026
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Smart Beta ETF report for IBD

AMEX · IBD
Financial Services · Asset Management - Bonds
$23.15
Up+$0.09 (+0.39%)
Updated Oct 15, 2026, 12:17 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · IBD
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 14, 2026
IBD closed at $23.15 after 21 trading sessions, down 0.60% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 14, 2026 | $22.96 | $23.50 | $22.815 | $23.15 | 63.23K |
| Oct 13, 2026 | $23.09 | $23.31 | $22.99 | $23.06 | 109.8K |
| Oct 12, 2026 | $23.05 | $23.0988 | $22.665 | $23.06 | 197.84K |
| Oct 9, 2026 | $23.04 | $23.56 | $22.50 | $23.17 | 425.75K |
| Oct 8, 2026 | $23.00 | $23.125 | $23.00 | $23.05 | 56.57K |
| Oct 7, 2026 | $22.97 | $23.5182 | $22.76 | $23.05 | 43.38K |
| Oct 6, 2026 | $23.02 | $23.325 | $23.015 | $23.12 | 95.1K |
| Oct 5, 2026 | $22.99 | $23.28 | $22.95 | $23.01 | 113.53K |
| Oct 2, 2026 | $23.05 | $23.16 | $22.52 | $23.02 | 60.41K |
| Oct 1, 2026 | $23.01 | $23.08 | $22.4962 | $23.01 | 132.22K |
| Sep 30, 2026 | $23.05 | $23.09 | $22.95 | $23.00 | 69.34K |
| Sep 29, 2026 | $22.99 | $23.195 | $22.92 | $23.02 | 56.78K |
| Sep 28, 2026 | $23.01 | $23.21 | $22.9401 | $23.00 | 46.78K |
| Sep 25, 2026 | $23.19 | $23.19 | $23.01 | $23.06 | 80.96K |
| Sep 24, 2026 | $23.21 | $23.39 | $23.1166 | $23.20 | 111.01K |
| Sep 23, 2026 | $23.31 | $23.40 | $23.1538 | $23.17 | 61.98K |
| Sep 22, 2026 | $23.38 | $23.42 | $23.30 | $23.34 | 68.5K |
| Sep 21, 2026 | $23.26 | $23.41 | $23.26 | $23.33 | 72.71K |
| Sep 18, 2026 | $23.4036 | $23.4036 | $23.28 | $23.32 | 48.08K |
| Sep 17, 2026 | $23.35 | $23.40 | $23.31 | $23.352 | 35.52K |
| Sep 16, 2026 | $23.33 | $23.6428 | $23.2601 | $23.29 | 72.35K |
The latest Smart Investors Daily articles mentioning IBD.
Company
Market Activity
Research & News
IBD research
Company profile and research snapshot.
The fund generally invests at least 80% of its total assets in the component securities of the index. The index provider selects domestic corporate bonds issued by companies that have market capitalizations of $5 billion or more, have credit ratings of BBB- or higher from Standard and Poor’s or Baa3 or higher from Moody’s and which have an Inspire Impact Score® of zero or higher.
Consensus and target data currently published for this company.
Generated Oct 15, 2026, 11:22 AM
Inspire Corporate Bond Impact ESG ETF (IBD) gained $0.09 (0.39%) today as investors continue evaluating its positioning in the fixed-income market. The modest move reflects cautious optimism around ESG-focused bond strategies, though questions persist about performance strength and relative value in the current rate environment.
Bottom line: IBD's modest gain reflects a market holding pattern rather than compelling momentum, with the fund trading at fair value according to recent analyst assessments. Investors should weigh the long-term ESG tailwind against near-term interest rate and credit risks, while monitoring whether the fund can deliver competitive yields relative to traditional corporate bond alternatives.
Yahoo · Oct 14, 2026
Smart Beta ETF report for IBD
Yahoo · Feb 2, 2026
Smart Beta ETF report for IBD
SeekingAlpha · Jan 26, 2026
Investors could get nervous with each jolt of turbulence, whether geopolitical, political, or monetary. Or they could put the noise-cancelling headphones on and focus on the destination.
SeekingAlpha · Jan 26, 2026
US blue-chip companiesâ borrowing costs relative to Treasuries have fallen. The cost of borrowing for IG companies stands at 0.73 percentage points above the equivalent on US government debt
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning IBD.